Thomas Flaten
Stock Analyst at Lake Street
(1.49)
# 3,298
Out of 4,883 analysts
26
Total ratings
37.04%
Success rate
-6.51%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AYTU Aytu BioPharma | Initiates: Buy | $8 | $2.29 | +249.34% | 1 | Jul 1, 2025 | |
| BDSX Biodesix | Maintains: Buy | $3 → $2 | $0.28 | +623.59% | 1 | May 14, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $40 → $35 | $20.50 | +70.73% | 6 | May 6, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $3.58 | +123.46% | 2 | Mar 7, 2025 | |
| EVAX Evaxion | Maintains: Buy | $35 → $6 | $2.49 | +140.96% | 2 | Feb 4, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $7.16 | +25.70% | 2 | Jan 8, 2025 | |
| DERM Journey Medical | Initiates: Buy | $9 | $6.94 | +29.78% | 1 | Sep 6, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.66 | +355.58% | 3 | Mar 12, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $2.23 | +393.27% | 3 | Mar 5, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $34 → $25 | $22.03 | +13.49% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $2.30 | +62,505.97% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $3.64 | +119.78% | 1 | Jul 7, 2022 |
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.29
Upside: +249.34%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.28
Upside: +623.59%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $20.50
Upside: +70.73%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.58
Upside: +123.46%
Evaxion
Feb 4, 2025
Maintains: Buy
Price Target: $35 → $6
Current: $2.49
Upside: +140.96%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $7.16
Upside: +25.70%
Journey Medical
Sep 6, 2024
Initiates: Buy
Price Target: $9
Current: $6.94
Upside: +29.78%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.66
Upside: +355.58%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $2.23
Upside: +393.27%
BioLife Solutions
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $22.03
Upside: +13.49%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $2.30
Upside: +62,505.97%
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $3.64
Upside: +119.78%